Mr Ted Agne

The Communications Strategy Group Inc. is US-based consultancy providing corporate/financial communications and business development services to the life sciences, biotech and medical technology sectors; assist and advise UK and EU companies seeking to expand to the US; corporate mentoring; assets partnering; capital formation.

The Communications Strategy Group Inc. acts as a contact point for UK companies attending US conferences, in partnership with Biopartner.co.uk, a UK Accredited Trade Organisation facilitating international partnering for trade, investment and collaborations with Life Sciences organisations across the UK. BioPartner is a membership organisation, supporting UK SMEs and startups, and signposting organisations worldwide to UK expertise.

Biopartner.co.uk has alliances with organisers of international biopartnering events, and with UK membership organisations, operating both independently and in partnership with the UK government. BioPartner disseminates tradeshow access grants to help UK-based SMEs exhibit their services and products in new overseas markets.

Organisation Type
BioPartner.co.uk & Communications Strategy Group
President 

Ms Lin Bateson

The Communications Strategy Group Inc. is US-based consultancy providing corporate/financial communications and business development services to the life sciences, biotech and medical technology sectors; assist and advise UK and EU companies seeking to expand to the US; corporate mentoring; assets partnering; capital formation.

The Communications Strategy Group Inc. acts as a contact point for UK companies attending US conferences, in partnership with Biopartner.co.uk, a UK Accredited Trade Organisation facilitating international partnering for trade, investment and collaborations with Life Sciences organisations across the UK. BioPartner is a membership organisation, supporting UK SMEs and startups, and signposting organisations worldwide to UK expertise.

Biopartner.co.uk has alliances with organisers of international biopartnering events, and with UK membership organisations, operating both independently and in partnership with the UK government. BioPartner disseminates tradeshow access grants to help UK-based SMEs exhibit their services and products in new overseas markets.

Organisation Type
BioPartner.co.uk & Communications Strategy Group
(not attending) 

Dr Eddie Blair

IMS offers magnetic antibodies and adaptor proteins to the life science community (research and bioprocessing) while further developing the technology platform for licensing and partnering opportunities in medicine (diagnostics and therapeutics).

Organisation Type
Integrated Magnetic Systems Ltd
Chief Executive Officer 

Dr John Burt

PolyTherics is a biotechnology company that offers a comprehensive range of site-specific conjugation technologies and polymer-based technologies which are being applied to the development and enhancement of biologicals and other therapeutic entities.

Organisation Type
PolyTherics Ltd
Chief Executive Officer 

Mr Andy Bush

Prosonix is a speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines enabled by its state-of-the-art particle engineering technology.

Organisation Type
Prosonix Ltd
Chief Operating Officer 

Mr Jeremy Curnock Cook

IBML, through its associate companies, OctaPhillip Bioscience Managers Ltd and Union MedTech PLC, specialises in investment in life science and medical technology companies.

Organisation Type
International Bioscience Managers
Managing Director 

Dr Jennifer Filbey

PolyTherics is a biotechnology company that offers a comprehensive range of site-specific conjugation technologies and polymer-based technologies which are being applied to the development and enhancement of biologicals and other therapeutic entities.

Organisation Type
PolyTherics Ltd
US consultant 

Mr David Hipkiss

Prosonix is a speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines enabled by its state-of-the-art particle engineering technology.

Organisation Type
Prosonix Ltd
Chief Executive Officer 

Dr Sarah Howell

Arecor has a proprietary and patented technology platform for improving the stability of a range of therapeutic proteins including vaccines, monoclonal antibodies, peptides, blood factors and fusion proteins

Website:
www.arecor.com
Organisation Type
Arecor Ltd
Chief Operations Officer 

Mr David Lawrence

Synpromics is a life science company focused on the field of synthetic biology. The Company's proprietary technology enables the design of optimized synthetic promoters that provide more effective and efficient gene regulation.

Organisation Type
Synpromics Ltd
Executive Chairman